Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients. (Q41204065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Pedro Rodríguez Quesada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Laura López Esteban

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jimena Ramón García

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Rocío Vázquez Sánchez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Teresa Molina García

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Gabriel Gaspar Alonso-Vega

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Javier Sánchez-Rubio Ferrández

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

1 reference

26 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Pharmacy

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

865-872

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11096-015-0132-1

15 February 2020

exact match

0 references

cites work

Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Renal toxicity associated with tenofovir use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Association of tenofovir exposure with kidney disease risk in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Renal toxicity of long-term therapy with tenofovir in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Antiretroviral therapy with tenofovir is associated with mild renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

HIV care and the incidence of acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Progression of renal impairment under therapy with tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Antiviral drug-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Predictors of Renal Outcome in HIV‐Associated Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Global epidemiology of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Tenofovir renal safety in HIV-infected patients: Results from the SCOLTA Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

Reacciones adversas del tratamiento antirretroviral: relación entre los síntomas percibidos y el cumplimiento terapéutico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-015-0132-1

21 January 2018

1 reference

12 December 2020

Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort

1 reference

12 December 2020

Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2

1 reference

12 December 2020

Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review

1 reference

12 December 2020

Tenofovir disoproxil fumarate-associated nephrotoxicity in HIV-infected patients: a prospective controlled study

1 reference

12 December 2020

Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir

1 reference

12 December 2020

Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study

1 reference

12 December 2020

10.1007/S11096-015-0132-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26008219%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference